Printer Friendly

MERIDIAN SIGNS DISTRIBUTION AGREEMENT FOR MAINLAND CHINA

 MERIDIAN SIGNS DISTRIBUTION AGREEMENT FOR MAINLAND CHINA
 CINCINNATI, Sept. 15 /PRNewswire/ -- Meridian Diagnostics


(NASDAQ/NMS: KITS) today announced the signing of an exclusive distribution agreement with TPI, Inc. of Lodi, N.J. for distribution of all of Meridian's products into Mainland China. Terms of the agreement include an initial stocking order and certain annual minimum sales levels.
 After substantial market research, TPI, Inc. has determined that there are significant markets for Meridian's products with emphasis on the FiltraCheck(TM) UTI and ImmunoCard(R) products. Product will be shipped during the fourth quarter and marketing will commence immediately.
 TPI, Inc., with experience in the global marketplace, functions as a marketing arm for volume oriented manufacturers in China. The management team is under the direct supervision of the Chinese Central Government. TPI has offices in Lodi, N.J. and Beijing and Xiaman, China.
 Jerry Ruyan, chief executive officer, said, "We are extremely pleased to have an alliance with a trading company to aggressively market our products in one of the largest potential medical marketplaces on the globe. It has been a goal of our company to find an outstanding distributor for this marketplace. We are pleased to have accomplished that task. We are optimistic that we will see solid sales through their efforts in Mainland China."
 Meridian Diagnostics, Inc. develops, manufactures and markets a variety of immunodiagnostic test kits, purified reagents such as antigens and monoclonal and polyclonal antibodies, and related diagnostic products. The company is a leader in the area of rapid diagnosis of infectious human diseases. All Meridian products are used outside the human body and require little or no special instrumentation or equipment. Domestic and international market segments consist of hospital, commercial and reference laboratories, and physicians' offices. The company has a leading market position in fungal serology, and is the leader in parasite and bacterial collection, preservation and transportation systems. The company's shares are traded through NASDAQ/NMS (Symbol: KITS).
 -0- 9/15/92 R
 /CONTACT: Jerry L. Ruyan of Meridian Diagnostics, Inc., 513-271-3700/
 (KITS) CO: Meridian Diagnostics, Inc. ST: Ohio IN: MTC SU:


BM -- CL011 -- 9712 09/15/92 14:45 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 15, 1992
Words:355
Previous Article:ARES-SERONO'S 1:5 STOCK SPLIT TO BE EFFECTIVE SEPT. 17, 1992
Next Article:ARES-SERONO'S EUROPEAN PATENT RIGHTS CONFIRMED: COMPANY TO CONTINUE ENFORCING ITS PATENT
Topics:


Related Articles
INCOMED CORP. SUBSIDIARY FEMTEK INC. SIGNS EXCLUSIVE LICENSING AGREEMENT FOR ASIA
MERIDIAN DIAGNOSTICS EUROPE SIGNS DISTRIBUTION AGREEMENT WITH INOVA DIAGNOSTICS INC.
H.K. to sign free-trade pact with China on June 30.
China, Macao sign free-trade pact.
China says ready for launching post service with Taiwan.
China, Taiwan start talks on aviation, financial services.
Human Pheromone Sciences Exclusive License Agreement for Its Initial Human Pheromone Technology in Taiwan.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters